- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05250999
Skin Stretch Sensory Stimuli and TENS in Diabetic Neuropathy
February 20, 2022 updated by: Riphah International University
Comparative Effects of Skin Stretch Sensory Stimuli and Transcutaneous Electrical Nerve Stimulation on Balance in Patients With Diabetic Neuropathy
The aim of the research was to find and compare the effects of skin stretch sensory stimuli and transcutaneous electrical nerve stimulation (TENS) on balance in diabetic neuropathy.
Randomized controlled trial done at District Headquarter hospital Okara.
The sample size was 46.
The subjects were divided into 3 groups, 15 subjects in skin stretch sensory stimuli group, 15 subjects in TENS group and 16 subjects in control group.
Study duration was of 6 month.
Sampling technique applied was convenient non-probability sampling.
Patients aged range from 45 to 80 years, having moderate peripheral neuropathy, and decrease sensations were included.
Tools used in this study were Berg Balance scale and Toronto clinical neuropathy score system.
Data was being analyzed through Spss 21.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Literature shows that various studies was done on diabetic patients for pain reduction, increase proprioception, improve muscle function and muscle recruitment by using kinesio tape and transcutaneous electrical nerve stimulation.
There is particularly limited literature available on the effects of skin stretch sensory stimuli on balance in DN patients.
Therefore, based on the literature study, there is crucial need for studying the effects of skin stretch sensory stimuli and TENS as a treatment approach.
Thus, the current study will be an attempt to know the results of skin stretch sensory stimuli and TENS in DN patients.
Study Type
Interventional
Enrollment (Actual)
46
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Okara, Punjab, Pakistan, 56300
- District Head Quarter Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- participants age ranged from 45 to 80 years' old
- Both genders.
- patients with moderate peripheral neuropathy 9-11 on Toronto Clinical Neuropathy Scoring system
- HbA1c levels
- peripheral neuropathic pain of >6 months' duration involving the lower extremities
- history of diabetes treated with diet, oral hypoglycemic or insulin therapy
- lower extremity symptoms such as muscle pain, decrease in sensations, Achilles tendon reflex, joint position sense of thumb
- Sensory polyneuropathy because of type 2 diabetic diseases
- Ability to walk household distance without assistance or with the use of assistive device such as cane.
Exclusion Criteria:
- Considerable musculoskeletal deformity such as fracture, amputation, abnormality of ROM.
- Previous history of knee or back surgery
- Lower extremity arthritis that prevents standing
- History of cardiovascular problems such as angina, MI
- Symptomatic postural hypotension
- Foot ulceration.
- Skin problems such as rashes etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Skin stretch sensory stimuli
Skin stretch sensory stimuli along with conventional physiotherapy
|
Skin stretch sensory stimuli will be exerted by a piece of kinesio tape that as applied above right and left lateral malleolus on posterior leg and on both side of spinous process of second thoracic vertebrae till 15cm below for 24 hours a day, 5 days/ week for 6 weeks along with conventional physiotherapy.
|
|
Experimental: Transcutaneous Electrical Nerve Stimulation
Transcutaneous electrical nerve stimulation along with conventional physiotherapy
|
TENS will be applied to patient while in sitting position for 30 minutes, twice a week, and for 6 weeks (12 treatment sessions along with conventional physiotherapy).
A maximum of 25 m amp electrical stimulation with a biphasic square-wave pattern and a pulse width of 0.5ms in a continuous duty cycle will be used.
The intensity of the electrical stimulation will be regulated to the high tolerable level without initiating muscle contractions.
|
|
Active Comparator: Control Group
Conventional physiotherapy included balance exercises, static exercise and dynamic exercise.
|
This program include balance exercises performed twice a week for 6 weeks, which consists of balance, progressive strength, and functional mobility training.
Static exercise consists of heel and toe raises, one-legged stance for each limb, weight shifting forward, backward, sideward and diagonally, and turning the head to the left and then to the right keeping the feet together.
This exercise comprises two 10-min sessions each, with eyes opened and eyes closed, respectively.
Dynamic exercise comprises of walking, step-ups, and bipedal jumps for 10 min.
Progressive balance exercises comprises of narrow walking, walking backward, walking sideward, stepping over obstacles, passing, throwing and catching a ball.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: 6th week
|
Berg balance scale is used to quantitively evaluate functional balance in older patients with balance disorders.
It is a reliable, valid and sensitive to change scale, that include 14 items, maximum score 56 and required 20-40 minutes for completion.
The score showed the patient's ability to control postural balance in which maximum score showed a good functional balance.
|
6th week
|
|
Toronto Clinical Neuropathy scoring system
Time Frame: 6th week
|
TCNS is a sensitive scoring system to diagnose diabetic neuropathy.
The Toronto Clinical Neuropathy Score (TCNS) is for the diagnosis and staging of diabetic neuropathy.
The score ranges from a minimum of 0 (no neuropathy) to a maximum of 19 points, and incorporates sensory and motor symptoms, as well lower limb sensory and reflex findings, and symptoms such as numbness, tingling, pain, weakness, ataxia and upper limb symptoms.
|
6th week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sara Aabroo, PPDPT, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 15, 2021
Primary Completion (Actual)
September 15, 2021
Study Completion (Actual)
December 15, 2021
Study Registration Dates
First Submitted
February 20, 2022
First Submitted That Met QC Criteria
February 20, 2022
First Posted (Actual)
February 22, 2022
Study Record Updates
Last Update Posted (Actual)
February 22, 2022
Last Update Submitted That Met QC Criteria
February 20, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/Lhr/21/0213 Sobia Younas
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.